Leonard A. Herzenberg
15Patents
10h-index
23Co-inventors
72Inventor score
Filing activity: Sep 22, 1982 → Apr 10, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5807715A | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin | Chemistry; Metallurgy | 564 | Expired |
| US5968738A | Two-reporter FACS analysis of mammalian cells using green fluorescent proteins | Physics | 129 | Expired |
| US4510244A | Cell labeling with antigen-coupled microspheres | Emerging Cross-Sectional Technologies | 109 | Expired |
| US4695459A | Method of treating autoimmune diseases that are mediated by Leu3/CD4 phenotype T cells | Emerging Cross-Sectional Technologies | 46 | Expired |
| US6077665A | Rapid assay for infection in neonates | Physics | 40 | Expired |
| US5070012A | Monitoring of cells and trans-activating transcription elements | Chemistry; Metallurgy | 38 | Expired |
| US6947953B2 | Internet-linked system for directory protocol based data storage, retrieval and analysis | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5968755A | Methods for determining T-cell profiles of immunocompromised subjects | Physics | 25 | Expired |
| US6566401B2 | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity | Human Necessities | 15 | Expired |
| US5607974A | Treatment of diseases associated with cysteine deficiency | Human Necessities | 10 | Expired |
| US7723389B2 | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity | Human Necessities | 4 | Expired |
| US5580577A | Method of treating the symptoms of human rhinovirus infection | Human Necessities | 3 | Expired |
| US7650351B2 | Internet-linked system for directory protocol based data storage, retrieval and analysis | Emerging Cross-Sectional Technologies | 3 | Active |
| US5843785A | Glutathione deficiency as a prognosis for survival in aids | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7981625B2 | Prostate cancer glycan markers and autoantibody signatures | Physics | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.